Cell Therapy for Chronic Stroke.

Stroke is a disease which adversely affects approximately 800,000 Americans every year. It is described as the third leading cause of death in America (200,000 per year) and the leading cause of disability, with up to $53.6 billion/year in direct and indirect costs to society. Symptoms include numbness in the limbs, weakness in facial muscles, slurred speech, loss of gait and balance, dizziness and severe headache.